t e C h n I C a l r e p O r t S Calcium signaling is studied as a potential form of astrocyte excitability that may control astrocyte involvement in synaptic and cerebrovascular regulation. Fundamental questions remain unanswered about astrocyte calcium signaling, as current methods can not resolve calcium in small volume compartments, such as near the cell membrane and in distal cell processes. We modified the genetically encoded calcium sensor GCaMP2 with a membrane-tethering domain, Lck, increasing the level of Lck-GCaMP2 near the plasma membrane tenfold as compared with conventional GCaMP2. Using Lck-GCaMP2 in rat hippocampal astrocyte-neuron cocultures, we measured near-membrane calcium signals that were evoked pharmacologically or by single action potentialmediated neurotransmitter release. Moreover, we identified highly localized and frequent spontaneous calcium signals in astrocyte somata and processes that conventional GCaMP2 failed to detect. Lck-GCaMP2 acts as a genetically targeted calcium sensor for monitoring calcium signals in previously inaccessible parts of astrocytes, including fine processes.
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Astrocytes tile the CNS, exert essential support functions 1 , provide energy metabolites to neurons 2 , and respond to injury and disease 3 . In addition, evidence suggests that astrocytes participate in synaptic function 4 and regulate blood flow to meet demands set by neuronal activity 5, 6 . The combination of timescale and cellular architecture involved in these responses suggests that certain astrocyte functions are regulated by rapid signaling events in distal processes that contact synapses or blood vessels.
Astrocytes display excitability in the form of intracellular calcium concentration increases that have been recorded in vitro 7 , in vivo [8] [9] [10] [11] [12] [13] and in brain slices from humans 14 . Astrocyte calcium transients occur spontaneously and are increased by neuronal activity 15 . As calcium is a ubiquitous second messenger, astrocyte calcium elevations may control communication with other cells. Communication between astrocytes and neurons is particularly intriguing because individual astrocytes contact many thousands of synapses 16, 17 and because electro physiological and imaging studies demonstrate the synaptic conse quences of second messenger signaling in astrocyte processes 18 .
Physiological experiments suggest two settings in which astrocytes and neurons may communicate. First, calcium levels in astrocytes are elevated in response to neurotransmitters released from neurons 19 .
Second, increases in astrocyte calcium cause the release of glutamate, which in turn affects neurons 20, 21 . These data suggest that calcium dependent 'gliotransmitter' release leads to short and longterm changes in neuronal and synaptic function 18, 22 . Nevertheless, calcium dependent astrocytetoneuron signaling is still debated and there is evidence both for 20, 21, 23, 24 and against it 25, 26 being a prevalent feature of CNS circuits. These issues have been discussed extensively 15, [27] [28] [29] [30] , raising awareness of the need for improved methods to selectively activate, silence and monitor astrocyte calcium signals.
Recent work has suggested that somatic calcium signals may be an unreliable measure of astrocyte excitability and its downstream signaling 31 . The controversy on the role of astrocyte calcium signals in influencing neuronal function may also be rooted in the fact that most experimental evidence stems from calcium measurements in somatic compartments, which is paradoxical when one considers that astrocytes are thought to signal at a local level via their distal processes 18, 29 . This situation exists because current methods can not measure calcium in small volume compartments such as astrocyte processes, which are too meager to adequately load with organic calcium indicator dyes 29 , although pioneering attempts have found distributed glial calcium signaling 32, 33 .
A direct method for monitoring calcium signals in astrocyte pro cesses is needed to elucidate if, when, where and how astrocytes affect neurons. Buoyed by recent advances using genetic targeting to achieve selective astrocyte ablation 34 , silencing of exocytosis 35 , as well as blockade 26 and activation 25 of astrocyte calcium signals, we devel oped a genetic strategy for monitoring realtime astrocyte calcium signaling selectively in nearmembrane regions and processes.
RESULTS

Global and near-membrane calcium signals
Protoplasmic astrocytes are known to have fine branches in vivo and it is thought that they signal locally in processes 29 . One problem in the study of astrocyte calcium signaling has been the inability to mea sure calcium in astrocyte processes with organic calcium indicator dyes 29 . Moreover, it is commonly assumed that a change in astrocyte calcium measured globally reflects similar changes near the plasma membrane, although this has not been directly investigated.
Using rat hippocampal astrocyteneuron cocultures, we studied spontaneous astrocyte calcium transients with epifluorescence (EPI) and total internal reflection fluorescence (TIRF) microscopy 36 , t e C h n I C a l r e p O r t S which measure global and nearmembrane calcium signals, respectively 36 (Fig. 1a) . We observed that 48% of 211 calcium transients (from 33 astrocytes) measured globally also elevated calcium near the plasma membrane in 10 ms; we referred to these as synchro nized events. This was readily visible by subtracting the normalized EPI and TIRF traces, resulting in a flat trace (Fig. 1b) . However, 50% of 211 calcium transients measured globally failed to elevate calcium near the plasma membrane; we referred to these as EPI unique events and the cells in which they occurred as being partially synchronized (Fig. 1c) . A further 2% of 211 events only elevated calcium near the plasma membrane (these were not examined further). In contrast with the differences observed for spontaneous calcium signals, application of 30 μM ATP to acti vate astrocyte P2Y 1 receptors increased calcium globally and near the membrane (Fig. 1b,c) . On average, the EPI unique events were smaller and briefer than the synchronous ones (dF/F values of 5 ± 4 and 30 ± 6% and half duration values of 5.4 ± 0.9 and 8.4 ± 1.0 s for EPI unique and synchronous events, respectively). Using ratiometric Fura2 imaging 37 , we estimated the change in cytosolic calcium con centration in three different conditions (Fig. 2a,b) , spontaneous cal cium signals (n = 50) and for signals evoked by 1 and 30 μM ATP (n = 65 and 103, respectively). We then repeated these experiments using Fluo4 and measured dF/F values for spontaneous and 1 and 30 μM ATPevoked calcium signals (n = 207, 18 and 56, respectively). Using both datasets, we determined a proportionality constant between the Fluo4 and Fura2 signals and used this to estimate the change in calcium concentration. Thus, synchronous events elevated calcium in the cytosol by ~300-400 nM, whereas EPI unique events elevated calcium in the cytosol by less than ~100 nM.
We examined the ability of G protein-coupled receptor (GPCR) agonists to elevate calcium globally and near the membrane of astrocytes. We used ATP (30 μM), glutamate (300 μM), DHPG (10 μM), TFLLR (30 μM) and ET1 (100 nM), which are agonists of P2Y 1 , mGluR, group I mGluR, PAR1 and endothelin1 receptors, respec tively. We also used FLRFa (5 μM) as an agonist of heterologously expressed MrgA1 receptors 25 . In each case, the GPCR agonists ele vated calcium levels globally and near the membrane with similar kinetics. Taken together, these experiments suggest that global mea sures of spontaneous astrocyte calcium transients do not accurately reflect calcium dynamics near the membrane and GPCR agonists do not mimic spontaneous astrocyte calcium signals in terms of ampli tude (Fig. 2c) or spread to the plasma membrane (Fig. 2) . We sought to develop an approach for measuring calcium in small volumes of astrocytes such as near the membrane and in fine processes.
GCaMP2 fails to measure spontaneous calcium signals
GCaMP2 is a genetically encoded green fluorescent protein (GFP) based calcium indicator that increases its fluorescence yield when calcium ions bind to the M13 and CaM fragments 38, 39 (Fig. 3a) . We used GCaMP2 because it is excited and emits at a single wavelength (488 and 508 nm, respectively) and has a calcium affinity of ~150 nM, close to that of organic calcium indicator dyes that have been used in past studies of astrocyte calcium signaling 29 . In addition, GCaMP2 kinetics are suited to astrocytes, which have transients that exist on a timescale of seconds 15 (Figs. 1 and 2) .
We expressed GCaMP2 in astrocytes to determine whether we could measure spontaneous calcium transients. GCaMP2 was robustly expressed in astrocytes (Supplementary Video 1) , but we failed to detect any spontaneous calcium transients in eight of eight cells with EPI or TIRF microscopy (imaged for 5 min each; Supplementary Video 1). We could, however, measure calcium elevations triggered by bath applications of GPCR agonists in all cells (for example, 30 μM ATP; Supplementary Video 2). From these data, we concluded that cytosolic GCaMP2 was not suitable for monitoring spontaneous astrocyte calcium transients.
Membrane targeted Lck-GCaMP2
One way to improve GCaMP2 is to optimize it through mutagenesis, but another approach is to target GCaMP2 to the plasma membrane, effectively increasing its local expression in a restricted volume. This should improve the signaltonoise ratio, as the reporter would be in the plane of the membrane in which calcium fluxes may be maxi mal. Cognizant of previous experiences with membrane tethers 40 , t e C h n I C a l r e p O r t S we used the Nterminal domain of Lck, a Src tyrosine kinase, which is known to con tain tandem palmitoylation and myristoyla tion domains 41, 42 .
We engineered GCaMP2 to carry the Nterminal 26 residue tag that we refer to as the Lck domain to generate LckGCaMP2 (Fig. 3a) , burying an Nterminal arginine residue that could render GCaMP2 susceptible to degradation 43 . For initial expression analy sis and characterization, we expressed LckGCaMP2 in HEK293 cells (Fig. 3) . In contrast with the cytosolic fluorescence of GCaMP2 (Fig. 3b) , we observed fluorescence that was localized to the edges of cells with LckGCaMP2 (Fig. 3c) . LckGCaMP2 also provided fluo rescence measurements of calcium ion concentration with a Ca 2+ K d of 168 ± 27 nM and Hill slope of 4.0 ± 1.0 (n = 9; Fig. 3d ), close to reported values for GCaMP2 (ref. 39 ).
Lck-GCaMP2 measures global astrocyte calcium signals
We expressed LckGCaMP2 in astrocytes and determined whether it was uniformly expressed in the membrane ( Supplementary  Fig. 1 ) by comparing TIRF images of astrocytes expressing LckGCaMP2 to those of cells expressing LckGFP and to astro cytes labeled with the membrane dye FM143. In all three cases, the TIRF images were similar, with no obvious puncta ( Supplementary  Fig. 1 ), indicating that LckGCaMP2 was uniformly distributed in the membrane.
We determined whether LckGCaMP2 could measure GPCR activation in astrocytes using ATP as a P2Y 1 agonist (Figs. 1, 2 and 4a) by employing rapid switching 44 t e C h n I C a l r e p O r t S TIRF microscopy were almost identical in their time course (Fig. 4b) and that the signals had the same ATP sensitivity, with halfmaximal effective concentration (EC 50 ) values of ~2 μM (EPI, 1.6 ± 0.2 μM; TIRF, 1.9 ± 0.2 μM; n = 10) and Hill slopes of ~2.6 (EPI, 2.6 ± 0.3; TIRF, 2.3 ± 0.1; n = 10; Fig. 4b,c) . These values are similar to the ATP EC 50 of 3.5 μM (n = 28-54) measured with Fluo4 (Fig. 4d) .
Lck-GCaMP2 measures neuron-to-astrocyte signaling We used hippocampal astrocyteneuron cocultures to determine whether LckGCaMP2 could measure signaling mediated by neuro transmitter release from neurons onto astrocytes 29 . We applied 1-180 action potentials at 30 Hz using electrical field stimulation (EFS) and plotted the change in fluorescence measured from astrocytes express ing LckGCaMP2 using EPI microscopy (Fig. 5a,b) . The peak dF/F was related to the number of action potentials between 1 and 60. In 7 of 11 astrocytes, a single action potential caused substantial increases in LckGCaMP2 fluorescence (0.37 ± 0.09, n = 7), which lasted 19.2 ± 4.8 s (quantified as T 0.5 ). The EFSevoked signals were reproducible when EFS was applied every 5 min (Fig. 5) .
We repeated the EFS experiments with tetrodotoxin (TTX, 1 μM, n = 5) or Cd 2+ (100 μM, n = 5) in the bath solution to block voltage dependent sodium and calcium channels, respectively, and found that the EFSevoked fluorescence changes were abolished (Fig. 5c-e) . On the basis of previous findings 45 , we examined whether ATP was released during EFS from neurons to mediate calcium signals in t e C h n I C a l r e p O r t S astrocytes. PPADS, a broad spectrum P2Y receptor antagonist, com pletely abolished the EFSevoked signals (30 μM, n = 5; Fig. 5e ). This is consistent with previous results on the functional expression of P2Y 1 receptors in astrocytes 29 . Consistent with this, the P2Y 1 receptor antagonist MRS2179 substantially decreased the responses evoked by EFS by ~40% (20 μM, n = 10; Fig. 5e) . Moreover, the EFSevoked responses were abolished when intracellular calcium stores were depleted with cyclopiazonic acid (CPA, 20 μM, n = 4).
Lck-GCaMP2 measures localized calcium signals
In contrast with cytosolic GCaMP2 (Supplementary Video 1) , we readily monitored spontaneous astrocyte calcium transients using LckGCaMP2 and EPI microscopy. We observed numerous brief and spotty calcium signals in astrocytes, events that we referred to as microdomains (Fig. 6a,b and Supplementary Videos 3 and 4) . By marking the area covered by each microdomain over 2 min of recording (Fig. 6a) , we determined that they covered 23 ± 8% (n = 8) of the astrocyte surface. Microdomains occurred randomly, independently of each other, repeatedly at the same location and displayed kinetics on a timescale of seconds (Fig. 6c) . The somatic microdomains had a fullwidth half maxima (FWHM) of 5.1 ± 0.1 μm (n = 6), greater than the point spread function of our microscope (~0.4 μm; Fig. 6d ).
Many microdomains (~80%) were in astrocyte cell bodies, with the remainder being present in astrocyte processes that extended >20 μm (Fig. 7a) . These latter microdomains were spatially and temporally distinct from somatic events (Fig. 7a) , but we found no substantial differ ences between microdomains in somata and processes in terms of dF/F, T 0.5 and frequency (Supplementary Table 1) . On average, we recorded 4.1 ± 1.6 microdomain locations per astrocyte (n = 8), with a mean T 0.5 of 3.9 ± 0.3 s (n = 408), a peak dF/F of 0.50 ± 0.01 (n = 515) and a frequency of 0.8 ± 0.07 events min −1 (159 microdomains, 56 cells).
Astrocytes in culture are flat, whereas they are more branched in situ. To recapitulate this more elaborate morphology, we treated the cells with 5 mM dbcAMP for 48 h, as this is known to cause astro cytes to extend processes 46 (Supplementary Fig. 2 and Supplementary Video 5). We readily detected spontaneous LckGCaMP2 fluorescence increases in these extended processes that were very similar to those in cells that were not treated with dbcAMP ( Fig. 7b and Supplementary  Table 1) . The spontaneous signals occurred up to 86 μm from the astrocyte cell body with a mean distance of 39 ± 5 μm (n = 22; Fig. 7b ). This is consistent with the length of astrocyte processes found in situ, between 17-51 μm 47 , indicating that LckGCaMP2 can report localized calcium signals in processes that are similar in length to those in intact preparations ( Fig. 7b and Supplementary Table 1) .
In contrast with the EFSevoked signals (Fig. 5) , microdomains were insensitive to 1 μM TTX (n = 6; Fig. 8a ). We also found that CPA (20 μM, n = 12) completely abolished ATPevoked calcium transients (Fig. 8) but spared the microdomains (n = 21) mea sured with LckGCaMP2 (Fig. 8b,d) . Conversely, we found that microdomains were abolished in calciumfree extracellular buff ers (n = 20), whereas the ATPevoked responses persisted (n = 10; Fig. 8c,d) . Moreover, incubation with the ATP receptor antagonist PPADS abolished ATPevoked signals (n = 11) but had no effect on microdomains (10 μM, n = 16; Fig. 8d) . Finally, activation of P2Y 1 and PAR1 GPCRs, alone or together, robustly elevated global calcium levels 31 , but failed to affect the frequency of microdomain calcium signals (Supplementary Fig. 3 ). Taken together, these experiments provide strong evidence that microdomain calcium signals are independent of GPCR activation and calcium release from intracellular stores but are dependent on transmembrane cal cium fluxes. Our data clearly show that LckGCaMP2 can be used to noninvasively monitor global (Fig. 4) , pharmacologically evoked (Fig. 4), electrically evoked (Fig. 5) and spontaneous calcium sig nals in astrocytes (Figs. 6-8) .
Further controls and characterization of Lck-GCaMP2
We imaged LckGCaMP2-expressing hippocampal neurons to determine whether astrocyte microdomain calcium signals were cell specific ( Supplementary Fig. 4 and Supplementary Table 1) and found several similarities and differences between neurons and astrocytes. First, ATP failed to evoke calcium signals in neurons but did so in astrocytes. In contrast, glutamate evoked similar signals in neurons and astrocytes ( Supplementary Fig. 4 and Supplementary  Table 1) . Second, we did not detect any spontaneous microdomains in nine of ten neurons ( Supplementary Fig. 4 t e C h n I C a l r e p O r t S microdomains in astrocytes were resistant to TTX (Fig. 8) . Fourth, LckGCaMP2 was equally well expressed in neurons and astrocytes (Supplementary Table 1) . Overall, our data indicate that micro domain calcium signals recorded in astrocytes with LckGCaMP2 are unlike signals measured in neurons.
Given that astrocytes in culture have intracellular vesicles and given that application of LckGCaMP2 results in uniform labeling of the plasma membrane (Supplementary Fig. 1 ), we next deter mined whether movement of fluorescent vesicles into a region of interest (ROI) could account for microdomain calcium signals (Supplementary Fig. 5) . First, the microdomains were abolished by removing extracellular calcium (Fig. 8) , which is strong evidence for transmembrane calcium fluxes rather than vesicle movement. Second, using LckGFP, the dF/F values resulting from vesicle movement into an ROI were tenfold smaller than dF/F values for microdomains mea sured with LckGCaMP2 ( Supplementary Fig. 5 and Supplementary  Video 7) . Third, the FWHM of LckGFP-labeled vesicles was at the resolution of our microscope at ~400 nm (Supplementary Fig. 5 ), whereas microdomains displayed FWHM of ~5 μm (Fig. 6d) . Thus, vesicle movement can not account for the microdomain calcium sig nals measured with LckGCaMP2.
We also considered the possibility that the astrocyte mem brane may be tortuous, leading to more LckGCaMP2 in spots, which may, in turn, lead to more robust calcium signals in these areas. We measured the fluorescence intensity of ROIs encompassing microdomains before they occurred and compared these values with those of the two nearest ROIs (2 and 5 μm away; Supplementary Fig. 6 ). We found that the basal fluorescence intensity of LckGCaMP2 was not different from that of the nearest ROIs that did not dis play microdomains. Within the limits of resolution, these data suggest that micro domain calcium signals are not a result of local accumulation of LckGCaMP2 (Supplementary Fig. 6 ).
We further characterized LckGCaMP2 expression in astrocytes (Supplementary Fig. 7) . First, we found that LckGCaMP2 was mainly expressed in the plasma membrane (Supplementary Fig. 7) , where it was ~14fold more abundant than GCaMP2 (Supplementary Fig. 7) . Second, the mobility of Lck GCaMP2 was substantially lower than that of cytosolic GCaMP2 (Supplementary Fig. 7) . Thus, our results suggest that high plasma membrane expression of a slowly diffusible indicator renders Lck GCaMP2 well suited to measure localized spontaneous microdomain calcium signals near the membrane and in restricted volumes of astrocyte processes on a timescale of seconds (Figs. 6-8) . Fig. 2) . Right, dF/F over time for seven microdomain signals.
t e C h n I C a l r e p O r t S DISCUSSION We developed LckGCaMP2, a genetically targeted calcium sensor that is tethered to the plasma membrane, and used it to moni tor distinct and previously unknown types of calcium signals in astrocytes, including signals localized in fine processes. In hippo campal astrocyteneuron cocultures, LckGCaMP2 detected near membrane calcium signals evoked pharmacologically or by single action potential-mediated neurotransmitter release. LckGCaMP2 also revealed highly localized, frequent spontaneous calcium sig nals in astrocyte somata and processes that conventional GCaMP2 failed to detect. We used TIRF microscopy in our characterization experiments because it offers excellent axial resolution for study ing signaling near the plasma membrane 36 . By necessity, we used cultured astrocytes, as TIRF can only be performed on cells that are attached to glass coverslips 36 . Although astrocytes in culture differ from those in vivo 48 , we believe that this does not detract from our finding that LckGCaMP2 is able to monitor calcium signaling near the plasma membrane and in fine processes of astrocytes.
The potential role of calcium signaling in distal astrocyte proc esses is important and understudied. Each hippocampal astrocyte may contact up to 100,000 synapses via its fine processes 16 . Calcium transients have mostly been measured from somatic regions of astro cytes. It remains unclear whether distal astrocyte processes have similar transients, whether calcium transients are compartmental ized or whether they are synchronous with the somatic regions. We attempted to measure differences between the soma and processes of astrocytes conventionally with Fluo4 in acute hippocampal slices and found that calcium transients appeared to be compartmentalized in astrocyte branches (Supplementary Fig. 8 ). These observations are consistent with previously published work 32, 33 and support the hypothesis that local compartmentalized calcium transients exist in astrocyte branches. However, these and other data are limited because the volume of the astrocyte processes is too meager to adequately load with calcium indicator dyes, highlighting the need for alternative approaches, such as LckGCaMP2. It is noteworthy that the micro domain calcium signals that we found in astrocyte processes using LckGCaMP2 are distinct from previous studies in Bergmann glia, which had microdomainlike signals as a result of calcium release from intracellular stores 33 . Thus, our finding of a membrane calcium flux pathway detected by LckGCaMP2 (Figs. 7 and 8) supports the emerging view that astroglia signal locally via their processes 18 .
Using cytosolic GCaMP2, we failed to detect spontaneous, presum ably physiological, astrocyte calcium transients 32 . Although cytosolic GCaMP2 can detect pharmacologically evoked calcium signals, we believe such pharmacological GPCRmediated signals are less inter esting and probably represent nonphysiological activation of astro cytes. Using nearly simultaneous EPI and TIRF microscopy, we found that pharmacologically evoked signals were fundamentally different in terms of amplitude and spatial spread in relation to spontaneous calcium signals, which were smaller and more restricted. The possibil ity that pharmacologically evoked calcium signals may be nonphysio logical has previously been raised 15, 29 .
Our characterization and proofofprinciple experiments indi cate that LckGCaMP2 is a substantial improvement over cytosolic GCaMP2 for detecting microdomain calcium signals in astrocytes. This approach can now be used to understand the settings in which calcium signals occur in individual astrocytes, which astrocytes display calcium signals in intact networks, and whether astrocyte processes generate calcium signals at their contact points with syn apses and blood vessels. Our findings with membranetargeted Lck GCaMP2 do not detract from recent work using expression of the cytosolic FRETbased calcium sensor yellow cameleon 3.6 (YC3.6) in astrocytes 49 . However, cytosolic YC3.6 expression may be best suited to study astrocyte cell bodies, as astrocyte processes were revealed as a "hazy cloud." Moreover, we believe our approach is simpler to imple ment, as LckGCaMP2 relies on a single wavelength for excitation (488 nm) and has a single emission peak (508 nm), making it ideal for standard single and multiphoton microscopes. Our data also sug gest that, by virtue of the membrane tether, LckGCaMP2 is better suited to image calcium in fine processes. TIRF microscopy indicated that LckGCaMP2 was uniformly and predominantly expressed in the plasma membrane and was present at high levels in astrocyte proc esses that have a high plasma membrane-tovolume ratio. Finally, the restricted mobility of LckGCaMP2 renders it better suited to detecting local point source-like calcium signals that arise as a result of calcium entry across the plasma membrane 50 .
We found that LckGCaMP2 was efficiently targeted to the plasma membrane and functioned similar to native GCaMP2 in terms of calcium affinity and sensitivity 39 . To the best of our knowledge, the Lck domain has not previously been used to target a calcium sensor to the plasma membrane, although its membrane targeting ability has been reported 41, 42 . Our data indicate that Lck efficiently recruited GCaMP2 to the plasma membrane, probably because it contains tan dem palmitoylation and myristoylation domains. Fluorescent proteins are continually being improved by redesign and mutagenesis. Recent modification of GCaMP2 to GCaMP3 led to a threefold improved expression and signaltonoise ratio that enabled tracking of spon taneous action potentials missed with GCaMP2 (ref. 43) . In com parison, LckGCaMP2 improves nearsurface expression in astrocytes by ~14fold and improved the signaltonoise ratio, resulting in the detection of spontaneous calcium signals not detected by cytosolic GCaMP2. In future studies, this Lck based strategy may be useful for determining the utility of new generations of genetically encoded calcium indicators.
The study of astrocyte calcium signaling and its potential effect on neuronal function is growing rapidly, but there are important unresolved issues. First, it is necessary to monitor astrocyte calcium signals in distal processes that contact synapses to test hypotheses on the role of astrocytes during synaptic transmission and plas ticity 15, 27, 29 . Second, it is necessary to monitor calcium signaling in astrocyte endfeet near blood vessels and relate these to vessel constriction and/or dilation 5, 6 . It will be important to extend our approach further by generating transgenic mice that express Lck GCaMP2 selectively in astrocytes. Third, LckGCaMP2 will be useful to identify the molecular basis of calcium signals in astro cytes using genome wide or targeted siRNA libraries. Technical advances often lead to breakthroughs in understanding complex problems; we believe that use of LckGCaMP2 in vitro and in vivo will reveal precisely how, when and where local calcium signaling occurs in astrocyte processes with relevance for astrocyte function, not only in healthy circuits, but also during reactive astrogliosis in specific injury and disease contexts 3 . Finally, LckGCaMP2 is likely to be useful for monitoring calcium signaling in other glial cells 28 (oligodendrocytes, NG2 cells, Schwann cells, microglia), and thus add to the repertoire of available methods for exploring their roles in brain.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
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